HomeTLIS • NASDAQ
add
Talis Biomedical Corp
Previous close
$8.95
Day range
$8.80 - $9.03
Year range
$4.35 - $9.60
Market cap
16.36M USD
Avg Volume
8.67K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 73.00K | -94.01% |
Operating expense | 14.18M | 121.66% |
Net income | -13.04M | 26.90% |
Net profit margin | -17.86K | -1,119.72% |
Earnings per share | — | — |
EBITDA | -13.86M | 26.39% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 70.34M | -37.73% |
Total assets | 82.49M | -38.00% |
Total liabilities | 25.81M | 12.56% |
Total equity | 56.68M | — |
Shares outstanding | 1.82M | — |
Price to book | 0.29 | — |
Return on assets | -39.84% | — |
Return on capital | -42.85% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -13.04M | 26.90% |
Cash from operations | -6.43M | 60.97% |
Cash from investing | 30.00K | 225.00% |
Cash from financing | 2.00K | -93.94% |
Net change in cash | -6.40M | 61.14% |
Free cash flow | -7.76M | 28.30% |
About
Founded
2013
Headquarters
Website
Employees
99